U.S. Life Sciences Stock News

NYSE:CURV
NYSE:CURVSpecialty Retail

Torrid Holdings (CURV) Posts First Quarterly Profit As Losses Challenge Bullish Turnaround Narrative

Torrid Holdings (CURV) opened Q1 2027 with total revenue of US$245.8 million, basic EPS of roughly US$0.00, net income of US$0.4 million and same store sales that fell 1.7% year over year. Over recent quarters the company has seen revenue move from US$265.97 million in Q1 2026 to US$245.8 million in Q1 2027, while basic EPS shifted from about US$0.06 in Q1 2026 to roughly US$0.00 in the latest quarter. With the trailing twelve month line still showing a loss and revenue effectively flat, this...
NYSE:ZBH
NYSE:ZBHMedical Equipment

A Look At Zimmer Biomet (ZBH) Valuation After Mixed Recent And Long Term Shareholder Returns

Why Zimmer Biomet Holdings (ZBH) is on investors’ radar today Zimmer Biomet Holdings (ZBH) has drawn attention after recent trading, with the stock closing at US$87.33 and showing mixed return patterns over the past year that contrast short term gains with longer term declines. See our latest analysis for Zimmer Biomet Holdings. Recent trading highlights this contrast clearly, with a 7 day share price return of 6.07% and a 30 day gain of 5.43%, set against a 1 year total shareholder return...
NasdaqGS:EA
NasdaqGS:EAEntertainment

Assessing Electronic Arts (EA) Valuation After A Period Of Steady Share Price Gains

Recent Price Moves and Business Snapshot Electronic Arts (EA) has been edging higher recently, with the stock up about 1% over the past month and 3% over the past 3 months, and last closing at US$203.00. The company reports annual revenue of US$7.53b and net income of US$887.0m, primarily from console, mobile, and PC free-to-download titles, with roughly US$4.50b generated internationally and US$3.03b from North America. See our latest analysis for Electronic Arts. While the share price has...
NYSE:BAX
NYSE:BAXMedical Equipment

Is Baxter International (BAX) Now A Potential Opportunity After Recent Share Price Rebound?

This article examines whether Baxter International at around US$19.38 is a bargain or a value trap, by breaking down what the current price could be implying about the stock. The stock has risen 3.2% over the past week and 14.1% over the past month, yet it is still down 0.6% year to date and has fallen 35.4% over the last 12 months. Recent coverage of Baxter International has focused on its role in healthcare equipment and on how investors are reassessing companies in this part of the...
NYSE:CMS
NYSE:CMSIntegrated Utilities

Assessing CMS Energy (CMS) Valuation After CFO Transition And Analyst Downgrade

Why the CFO transition and downgrade matter for CMS Energy (CMS) Jefferies recently downgraded CMS Energy (CMS) after the unexpected retirement of CFO Rejji Hayes and the appointment of Sri Maddipati as his successor, highlighting questions around future data center growth and the NorthStar business. For you as an investor, these developments put the focus squarely on how the new finance leadership approaches capital allocation, communication with markets, and decisions about NorthStar Clean...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

Enphase SST Push Positions Company For AI Data Center Opportunity

Enphase Energy (NasdaqGM:ENPH) management has highlighted the potential of its solid-state transformer, or SST, system for AI data centers. The company pointed to upcoming commercial demonstrations of the SST platform and described a sizable addressable opportunity in the U.S. market. This is the first time management has laid out specific detail on how SST could extend Enphase beyond its core residential solar focus. For investors tracking Enphase Energy, the SST update comes as the stock...
NYSE:DHR
NYSE:DHRLife Sciences

Reassessing Danaher (DHR) Valuation After Mixed Share Performance And Conflicting Undervaluation Signals

Why Danaher (DHR) is Drawing Investor Attention Now Danaher (DHR) is back in focus as investors reassess the company after a mixed stretch for the stock, including a decline year to date alongside modest recent gains over the past month. See our latest analysis for Danaher. Recent trading shows a 5.36% 30 day share price return, while the year to date share price return is down 20.01% and the 5 year total shareholder return is down 13.86%. This indicates that short term momentum is improving,...
OTCPK:FGPR
OTCPK:FGPRGas Utilities

Ferrellgas Partners (OTCPK:FGPR) Profit Return Challenges Bearish Earnings Narratives

Ferrellgas Partners (OTCPK:FGPR) has just posted its Q2 2026 numbers, with revenue of US$641.4 million and basic EPS of US$2.51. The trailing twelve month figures show revenue of about US$1.9 billion and basic EPS of US$1.31, as earnings have shifted from earlier losses into profit over the past year. Over recent quarters, revenue has ranged from US$343.6 million to US$669.8 million and basic EPS has swung between a loss of US$18.83 and a profit of US$2.51. This sets up a story where margins...
NasdaqGS:ITRI
NasdaqGS:ITRIElectronic

Is Itron (ITRI) Undervalued After Recent Share Price Weakness And A US$135 Fair Value Estimate

Recent performance snapshot Itron (ITRI) has been under pressure recently, with the stock down about 3% over the past month and about 12% over the past 3 months, and the one year total return down roughly 34%. At a recent close of US$80.07 and a market cap of about US$3.6b, the company reports annual revenue of US$2.35b and net income of US$289.04m, with yearly revenue and net income growth figures provided at 5.0% and 2.6% respectively. See our latest analysis for Itron. The recent share...
NYSE:ELF
NYSE:ELFPersonal Products

Does e.l.f. Beauty's (ELF) Rising Short Interest Recast Its Risk‑Reward Narrative for Investors?

In late May 2026, e.l.f. Beauty highlighted its profile with an investor presentation at the Baird Global Consumer, Technology & Services Conference in New York, underscoring its engagement with the financial community. Shortly afterward, Jim Cramer’s televised comments on e.l.f. Beauty’s volatile trading, sizable short interest, and reliance on Chinese supply chains sharpened investor focus on the brand’s risk-reward balance. Next, we’ll examine how this heightened attention to e.l.f...
NYSE:UPS
NYSE:UPSLogistics

A Look At United Parcel Service’s Valuation After Recent Share Price Momentum

UPS stock performance snapshot United Parcel Service (UPS) has drawn fresh attention after recent trading, with the stock last closing at US$108.54. Investors are weighing this price against the company’s current business scale and recent return profile. Over the past month, UPS shares gained about 8.7%, while the past 3 months added roughly 6.0%. The stock is up around 7.4% year to date and about 18.1% over the past year, though the 3 year and 5 year total returns show declines of roughly...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

What GitLab (GTLB)'s AI-Focused Restructuring and Share Buyback Mean For Shareholders

In early June 2026, GitLab Inc. reported first-quarter fiscal 2027 results showing revenue of US$264.16 million and a net loss of US$4.97 million, alongside new guidance calling for second-quarter revenue of US$272 million–US$274 million and full-year revenue of US$1.11 billion–US$1.12 billion. At the same time, GitLab completed a US$50.05 million share repurchase and announced an “Act Two” restructuring to cut about 14% of staff and reinvest savings into its AI-driven Duo Agent Platform and...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

CABINET Results Broaden CABOMETYX Neuroendocrine Reach And Investor Considerations

Exelixis reported new phase 3 CABINET trial data for CABOMETYX in advanced neuroendocrine tumors. The subgroup analysis showed significant improvements in progression free survival regardless of tumor functional status. These data were presented at ASCO 2026 and expand the evidence base for CABOMETYX in neuroendocrine tumors. For investors following NasdaqGS:EXEL, the CABINET subgroup results arrive with the stock at $52.7 and strong recent returns, including 20.9% year to date and 22.5%...
NYSE:RCUS
NYSE:RCUSBiotechs

A Look At Arcus Biosciences (RCUS) Valuation After Recent Share Price Weakness

Recent stock performance and business context Arcus Biosciences (RCUS) has drawn attention after recent share price moves, with the stock down 6.1% on the day and about 10.8% over the past month, while still up over the past 3 months. At a recent close of US$23.19 and a market value of around US$3.1b, the company remains a clinical stage cancer therapy developer with revenue of US$236.0m and a reported net loss of US$369.0m. See our latest analysis for Arcus Biosciences. Recent moves have...
NYSE:ZETA
NYSE:ZETASoftware

A Look At Zeta Global Holdings (ZETA) Valuation After Strong Earnings Beat And Raised Full Year Guidance

Zeta Global Holdings (ZETA) is back in focus after its latest earnings report, where revenue grew 49.9% year on year, beat expectations by 7%, and the company raised full year guidance more than its peers. See our latest analysis for Zeta Global Holdings. At a share price of $22.02, Zeta Global’s 30 day share price return of 27.8% and 1 year total shareholder return of 58.3% suggest momentum has picked up recently despite a softer 7 day patch. If strong software earnings have your attention,...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

Do Sharplink’s (SBET) Upgraded Earnings Estimates Reveal a Turning Point in Its Investment Narrative?

Recently, Zacks Investment Research upgraded Sharplink Inc. (SBET) to a Rank #2 (Buy), citing an upward trend in the company’s earnings estimates. This reassessment of Sharplink’s earnings outlook highlights how revisions in expectations can influence investor perception of the business’s longer-term potential. Next, we’ll explore how this improved earnings outlook, reflected in the Zacks upgrade, shapes Sharplink’s broader investment narrative. Invest in the nuclear renaissance through our...
NYSE:FDP
NYSE:FDPFood

Fresh Del Monte Produce (FDP) Valuation Check As Del Monte Foods Expands Pittsburgh Partnership And Hub Role

Fresh Del Monte Produce (FDP) is in focus after its Del Monte Foods division announced a multi-year partnership with the Pittsburgh Pirates, while also naming Pittsburgh as the operational hub for its Foods Division. See our latest analysis for Fresh Del Monte Produce. The new Pittsburgh partnership comes after a tougher stretch for the stock, with the 30 day share price return down 21.28% and the 90 day share price return down 30.70%. The three year total shareholder return sits at 21.86%,...
NasdaqGM:BLBD
NasdaqGM:BLBDMachinery

Assessing Blue Bird (BLBD) Valuation After Strong Recent Share Price Momentum

Recent performance context for Blue Bird Without a single headline event driving attention, Blue Bird (BLBD) has still been on many investors’ radar after recent share price moves and solid reported figures for revenue, net income and returns. See our latest analysis for Blue Bird. At a share price of US$71.95, Blue Bird’s recent 30-day share price return of 13.50% and year to date share price return of 53.87% sit alongside a 1-year total shareholder return of 78.54%. This suggests momentum...
NYSE:APO
NYSE:APODiversified Financial

The Bull Case For Apollo Global Management (APO) Could Change Following $35 Billion AI Compute Platform Push

Apollo Global Management has recently deepened its role in the AI infrastructure build-out through a planned US$35.00 billion AI compute platform with Broadcom, while also advancing logistics real estate fundraising and completing new private equity transactions. At the same time, Apollo is reinforcing its differentiated model that pairs retirement-focused capital from Athene with large-scale alternative investments, while facing fresh regulatory and valuation scrutiny around private credit...
NYSEAM:UEC
NYSEAM:UECOil and Gas

Does Uranium Energy (UEC) Gain Strategic Leverage From Urenco’s U.S. Enrichment Expansion And Policy Shifts?

Uranium Energy recently benefited from Urenco’s decision to expand uranium enrichment capacity at the only commercial U.S. facility, combined with U.S. moves to phase out Russian uranium imports by 2028 and rising nuclear power interest tied to AI-driven electricity demand. This combination of domestic enrichment growth, geopolitical supply shifts and data-center energy needs highlights how policy and technology trends can reshape uranium miners’ long-term commercial opportunities. We’ll now...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Regulators Weigh Paramount Skydance Deal As WBD Streaming Turns Profitable

Paramount Skydance's acquisition of Warner Bros. Discovery (NasdaqGS:WBD) is moving through global regulatory reviews, including a formal process in Europe. U.S. attorneys general are examining potential competition and industry impacts from the proposed Hollywood combination. Warner Bros. Discovery has reported a profitable streaming segment and recorded a substantial, one off merger related fee that resulted in a large loss. Warner Bros. Discovery, the media and entertainment group behind...
NYSE:SIG
NYSE:SIGSpecialty Retail

Raised Guidance And New Buyback Might Change The Case For Investing In Signet Jewelers (SIG)

In early June 2026, Signet Jewelers reported first-quarter Fiscal 2027 results with modest revenue growth to US$1,553.6 million, slightly lower net income of US$31.7 million, raised full-year sales and earnings guidance, declared a US$0.35 quarterly dividend for August 21, 2026, and continued returning capital via share repurchases including a new US$50 million accelerated program. These updates highlight management’s confidence in its Grow Brand Love restructuring, as positive same-store...
NYSE:AR
NYSE:AROil and Gas

A Look At Antero Resources (AR) Valuation As Shares Trade Below Narrative Fair Value

What is moving Antero Resources stock now? Antero Resources (AR) has drawn fresh attention after recent trading, with the stock closing at US$35.56. Investors are weighing that price against the company’s reported US$5.63b in revenue and US$961.66m in net income. See our latest analysis for Antero Resources. Recent trading has been choppy, with the 1-day share price return down 4.15% and the 90-day share price return down 8.42%, even though the year-to-date share price return is up 3.95%...
NYSE:OII
NYSE:OIIEnergy Services

3 High‑Quality Undiscovered Gems With Standout ROE And Margins

With inflation pressures tied to energy and freight, shifting central bank policies, and uneven growth across regions, many investors are looking beyond the usual large cap stocks. That is where the High-Quality Undiscovered Gems screener comes in. It focuses on smaller companies with solid fundamentals that are less crowded by big funds. By targeting stocks that are not heavily owned by institutions, you are not just following the usual playbook; you are looking where others are not paying...